Hypertension – The Silent Killer

Katarzyna Sawicka, Michał Szczyrek, Iwona Jastrzębska, +3

Journal of Pre-Clinical and Clinical Research

HypertensionSilent KillerCardiovascular DiseaseAntihypertensive TherapyHypertensive Emergencies +3

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

Anna Grenda, Ewelina Iwan, Izabela Chmielewska, +11

AMB Express

Immunotherapy EffectivenessCancer ImmunosurveillanceAllergyMalignant DiseaseMedicine +13

Chronic obstructive pulmonary disease in farmers and agricultural workers - an overview.

Michał Szczyrek, Paweł Krawczyk, Janusz Milanowski, +3

PubMed

AsthmaPulmonary CareAdvanced Lung DiseaseLung InflammationAirflow Obstruction +16

Promoter polymorphisms of <i>TOP2A</i> and <i>ERCC1</i> genes as predictive factors for chemotherapy in non‐small cell lung cancer patients

Anna Grenda, Justyna Błach, Michał Szczyrek, +9

Cancer Medicine

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients

Anna Grenda, Ewelina Iwan, Paweł Krawczyk, +11

Cancers

DysbiosisKlebsiella PneumoniaeImmunologyPathologyGut Microbiota +19

Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients

Aneta Szudy‐Szczyrek, Radosław Mlak, Magdalena Bury‐Kamińska, +9

British Journal of Haematology

Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen

Aneta Szudy‐Szczyrek, Radosław Mlak, Michał Mielnik, +9

Annals of Hematology

MicroRNAs aid the assessment of programmed death ligand�1 expression in patients with non‑small cell lung cancer

Anna Grenda, Marcin Nicoś, Michał Szczyrek, +8

Oncology Letters

Pd-l1-positive Tumor CellsImmunologyCell DeathPathologyImmunotherapy +20

Diagnostic value of plasma expression of microRNAs complementary to Drosha and Dicer in lung cancer patients.

Michał Szczyrek, Barbara Kuźnar-Kamińska, Anna Grenda, +12

PubMed

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

Anna Grenda, Paweł Krawczyk, Justyna Błach, +23

Frontiers in Oncology